Experienced in Low Sodium Level

Jean-yves Y. Lefrant

CHU Nîmes
Nimes, FR 
Experienced in Low Sodium Level
CHU Nîmes
Nimes, FR 
OverviewLocationsClinical Research

Overview

Jean-yves Lefrant practices in Nimes, France. Lefrant is rated as an Experienced expert by MediFind in the treatment of Low Sodium Level. Their top areas of expertise are Sepsis, Pneumonia, Severe Acute Respiratory Syndrome (SARS), Cerebral Hypoxia, and Appendectomy.

Their clinical research consists of co-authoring 154 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Low Sodium Level.

Locations

CHU Nîmes
Nimes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock: A Multicenter, Stepped Wedge Cluster Randomized Trial
Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock: A Multicenter, Stepped Wedge Cluster Randomized Trial
Enrollment Status: Completed
Publish Date: September 19, 2025
Intervention Type: Other
Study Phase: Not Applicable
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury: a Multicentre, Randomized, 2-parallel Group, Superiority Trial
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury: a Multicentre, Randomized, 2-parallel Group, Superiority Trial
Enrollment Status: Terminated
Publish Date: August 26, 2025
Intervention Type: Drug
Study Drug: L-Carnitine
Study Phase: Phase 3
Sevoflurane for Sedation in Acute Respiratory Distress Syndrome: a Multicenter Prospective Randomized Trial
Sevoflurane for Sedation in Acute Respiratory Distress Syndrome: a Multicenter Prospective Randomized Trial
Enrollment Status: Completed
Publish Date: October 23, 2024
Intervention Type: Drug
Study Drugs: Inhaled sedation with sevoflurane, Intravenous sedation with propofol
Study Phase: Phase 3
Immunological Profiling of Patients With COVID-19 in Respiratory Distress
Immunological Profiling of Patients With COVID-19 in Respiratory Distress
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Other
Analysis of the Coagulopathy Developed by COVID-19 Infected Patients: Thrombin Generation Potential in COVID-19 Infected Patients
Analysis of the Coagulopathy Developed by COVID-19 Infected Patients: Thrombin Generation Potential in COVID-19 Infected Patients
Enrollment Status: Completed
Publish Date: October 03, 2022
Intervention Type: Other
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Other
Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections)
Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections)
Enrollment Status: Completed
Publish Date: October 05, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
Stress Post Traumatique, Signes de dépression et Syndrome d'épuisement Professionnel Chez le Personnel Des EHPAD en Occitanie Pendant la pandémie COVID-19 : étude Prospective
Stress Post Traumatique, Signes de dépression et Syndrome d'épuisement Professionnel Chez le Personnel Des EHPAD en Occitanie Pendant la pandémie COVID-19 : étude Prospective
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Other
Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey
Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey
Enrollment Status: Completed
Publish Date: December 19, 2020
A MULTICENTER, RANDOMIZED, CONTROLLED STUDY OF EPIDURAL ANALGESIA FOR SEVERE ACUTE PANCREATITIS
A MULTICENTER, RANDOMIZED, CONTROLLED STUDY OF EPIDURAL ANALGESIA FOR SEVERE ACUTE PANCREATITIS
Enrollment Status: Completed
Publish Date: May 01, 2020
Intervention Type: Other
Study Phase: Phase 3
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Enrollment Status: Completed
Publish Date: March 23, 2020
Intervention Type: Other, Biological
Study Phase: Phase 2
Comparison of Two Strategies for Setting Positive End-Expiratory Pressure in Acute Lung Injury/ Acute Respiratory Distress Syndrome (ExPress Study).
Comparison of Two Strategies for Setting Positive End-Expiratory Pressure in Acute Lung Injury/ Acute Respiratory Distress Syndrome (ExPress Study).
Enrollment Status: Completed
Publish Date: March 22, 2019
Intervention Type: Device
Study Phase: Not Applicable
Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis
Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis
Enrollment Status: Completed
Publish Date: January 25, 2019
Intervention Type: Drug
Study Phase: Phase 4
Automated Administration of Intravenous Fluids Guided by Dynamic Parameters and Cardiac Output During General Anesthesia: a Pilot Feasibility Study
Automated Administration of Intravenous Fluids Guided by Dynamic Parameters and Cardiac Output During General Anesthesia: a Pilot Feasibility Study
Enrollment Status: Terminated
Publish Date: January 03, 2018
Intervention Type: Device
Study Phase: Phase 2
View 13 Less Clinical Trials

154 Total Publications

Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.
Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.
Journal: Intensive care medicine
Published: May 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lefrant's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile